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The embryonic cardiac outflow myocardium originates from a secondary heart-forming field to connect the developing ventricles with the
aortic sac. The outflow tract (OFT) subsequently undergoes complex remodeling in the transition of the embryo to a dual circulation. In
avians, elimination of OFT cardiomyocytes by apoptosis (stages 25–32) precedes coronary vasculogenesis and is necessary for the
shortening of the OFT and the posterior rotation of the aorta. We hypothesized that regional myocardial hypoxia triggers OFT remodeling. We
used immunohistochemical detection of the nitroimidazole EF5, administered by intravascular infusion in ovo, as an indicator of relative
tissue oxygen concentrations. EF5 binding was increased in the OFT myocardium relative to other myocardium during these stages (25–32)
of OFT remodeling. The intensity of EF5 binding paralleled the prevalence of apoptosis in the OFT myocardium, which are first detected at
stage 25, maximal at stage 30, and diminished by stage 32. Evidence of coincident hypoxia-dependent responses included the expression of
the vascular endothelial growth factor (VEGF) receptor 2 by the OFT myocardium, the predominant expression of VEGF122 (diffusible)
isoform in the OFT, and the recruitment of QH1-positive pro-endothelial cells to the OFT and vasculogenesis. Exposure of embryos to
hyperoxia (95% O2/5% CO2) during this developmental window reduced the prevalence of cardiomyocyte apoptosis and attenuated the
shortening and rotation of the OFT, resulting in double-outlet right ventricle morphology, similar to that observed when apoptosis is directly
inhibited. These results suggest that regional myocardial hypoxia triggers cardiomyocyte apoptosis and remodeling of the OFT in the
transition to a dual circulation, and that VEGF autocrine/paracrine signaling may regulate these processes.
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Introduction circuits by septation, a process dependent on invasion ofThe embryonic cardiac outflow tract (OFT) connects the
developing ventricles to the aortic sac. In birds and mam-
mals, the OFT myocardium is added from a ‘secondary
(anterior) heart-forming field’ from splanchnic mesoderm
beneath the caudal pharynx, well after the formation of the
primitive heart tube from the primary heart-forming field
(Kelly et al., 2001; Mjaatvedt et al., 2001; Waldo et al.,
2001). In the subsequent transition to a dual circulation, the
OFT undergoes complex remodeling (reviewed in Pexieder,
1995). The OFT is divided into pulmonary and systemic0012-1606/$ - see front matter D 2003 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2003.11.017
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E-mail address: saf9@po.cwru.edu (S.A. Fisher).cells from the neural crest (Kirby et al., 1983). The OFT also
shortens and rotates for the pulmonary artery to connect to
the right ventricle in a position anterior and to the right of
the aorta’s connection to the left ventricle (De la Cruz et al.,
1977; Thompson et al., 1987; Watanabe et al., 1998).
We have provided several lines of evidence that suggest
that removal of OFT cardiomyocytes by apoptosis mediates
the shortening and rotation of the OFT in the transition to a
dual circulation. We have shown that elimination of cardi-
omyocytes by apoptosis in the OFT coincides with its
shortening and rotation (Watanabe et al., 1998). Both
apoptosis and shortening/rotation occur between Hamburg-
er–Hamilton (HH) stages 25–32 (Hamburger and Hamil-
ton, 1951), and at the peak at stages 30–31, as many as 50%
of the OFT cardiomyocytes undergo apoptosis (Watanabe et
al., 1998). With the use of adenoviral-expressed LacZ or
green fluorescent protein (GFP) tags, we showed that the
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myocardial infundibular connection of the right ventricle to
the pulmonary artery (Watanabe et al., 1998, 2001). Tar-
geted inhibition of OFT cardiomyocyte apoptosis attenuates
OFT shortening and the rotation of the aorta to a posterior
position, resulting in double-outlet right ventricle (Watanabe
et al., 2001). This provides experimental evidence that OFT
cardiomyocyte apoptosis drives the shortening and rotation
of the OFT. However, the trigger for this aspect of OFT
remodeling is not known.
We hypothesized that tissue hypoxia may be a trigger for
OFT remodeling for several reasons. First, it is assumed that
the dual-series circulation, in which deoxygenated blood
transits the pulmonary circuit and oxygenated blood transits
the systemic circuit, evolved in warm-blooded animals
(birds and mammals) to more efficiently deliver oxygen to
the tissues. The implication is that this arrangement of the
circulation developed as a response to tissue hypoxia.
Second, the OFT remodeling involves both cardiomyocyte
apoptosis (Hurle et al., 1977; Icardo, 1990; Pexieder, 1995;
Watanabe et al., 1998) and pro-endothelial cell invasion
(Rothenberg et al., 2002), both of which in other contexts
may be triggered by tissue hypoxia (reviewed in Bishopric
et al., 2001; Carmeliet and Collen, 2000). A number of
studies have examined the role of hypoxia during develop-
ment using differing approaches. One approach is the use of
nitroimidazole chemicals, such as EF5 [2-(2-nitro-1H-imi-
dazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide] and
pimonidazole, which are reduced by nitroreductases under
hypoxic conditions and form covalent adducts in cells, and
thus serve as indicators of relative oxygen concentrations
(Koch, 2002; Lee et al., 2001). A second approach has been
to examine the expression of hypoxia-inducible transcrip-
tion factors (HIF), their target genes, and the effects of
inactivation of these genes on cardiovascular development
(Carmeliet et al., 1996; Ferrara et al., 1996; Kotch et al.,
1999; Maltepe et al., 1997; Peng et al., 2000). This approach
showed that development of the circulation requires hypox-
ia-dependent transcriptional responses, but because of the
embryonic lethality, the specific role of hypoxia and hyp-
oxia-dependent responses in the transition to a dual circu-
lation remains uncertain.
To determine the role of hypoxia in the apoptotic
remodeling of the avian OFT, we used the nitroimidazole
EF5 as a surrogate marker of tissue oxygen concentrations
(Evans et al., 1995; Shapiro et al., 1997), and the expression
of vascular endothelial growth factor (VEGF) and VEGF
receptor 2 and vasculogenesis as indicators of a response to
tissue hypoxia (Waltenberger et al., 1996). The role of
hypoxia as a trigger for the remodeling of OFT was tested
experimentally by exposing embryos in ovo to hyperoxia
during the specific developmental window of OFT remod-
eling. Our results suggest that regional myocardial hypoxia
triggers a unique program of gene expression in the OFT
myocardium and is necessary for the apoptotic remodeling
of the avian OFT in the transition to a dual circulation.Materials and methods
Animals and exposure to hyperoxia
Fertile White Leghorn (Gallus gallus) chicken eggs
were obtained from Squire Valleevue Farm (Cleveland,
OH). Fertile quail (Cortunix cartunex japonica) eggs were
obtained from G.Q.F. Manufacturing Co. (Savannah, GA).
Eggs were incubated in a humidified room air incubator at
38jC until the embryos grew to appropriate stages for each
experiment [generally Hamburger–Hamilton (HH) stages
25–32 (ED 4–8)]. For exposure to hyperoxia, eggs were
then placed in a sealed chamber (Modular Incubator
Chamber, Billups–Rothenberg, Inc., Del Mar, CA) with
water and the chamber was set in a humidified incubator
(Circulated Air Incubator Model 1250, G.Q.F. Manufac-
turing). The sealed chamber was flushed with 95% O2/5%
CO2 for 10 min to exchange the inside air completely, and
then the inlet and outlet tubes were clamped. The chamber
was flushed with oxygen gas on a daily basis to maintain
hyperoxia. Eggs were incubated for 3 days to reach stage
32. Control eggs were incubated in the same chamber in
room air. For exposure to hypoxia, eggs were incubated in
a Water Jacketed CO2 Incubator (Model 3130, Forma
Scientific, Inc., Marietta, OH) in which oxygen concentra-
tion was automatically set and controlled by the infusion
of nitrogen gas.
Immunohistochemistry
Embryos were fixed in fresh 4% paraformaldehyde at
4jC for the appropriate time (1–2 h) for each experiment,
and cryosections with 10-Am thickness were made from the
fixed embryos. The primary antibodies used in this study
were anti-EF5 antibody conjugated with Cy3 (from Dr. C.
Koch) without dilution; mouse anti-VEGFR2 IgG1 (kindly
provided by Dr. Eichmann) without dilution; QH1, a
specific marker for endothelial cells (obtained from Hybrid-
oma Bank) at 1:100 dilution; Sr-1, an antibody against
sarcomeric actin (DAKO, Carpinteria, CA) at 1:200 dilu-
tion; and MF20, an antibody against myosin (obtained from
Hybridoma Bank) at 1:200 dilution. QH1, Sr-1, and MF20
were detected with an appropriate secondary antibody
conjugated with Alexa Fluor 488 (Molecular Probes,
Eugene, OR). Anti-VEGFR2 antibody was detected with
goat antimouse IgG secondary antibody conjugated with
biotin (Vector, Burlingame, CA), and the signal was ampli-
fied with the TSA systems with fluorescein isothiocyanate
(FITC) (Perkin Elmer, Boston, MA) according to the
manufacturer’s instructions. Selected sections stained with
anti-VEGFR2 antibody were also stained with phalloidin
conjugated with Alexa Fluor 568 (Molecular Probes) to
delineate myocardium. Sections were observed with a
fluorescent microscope (Leica DM LB, Leica Microsys-
tems, Wetzlar, Germany) and images were captured with
SPOT RT camera and software v3.1 (Diagnostic Instru-
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tained with anti-VEGFR2 antibody and phalloidin-Alexa
Fluor 568 were also observed with a laser scanning confo-
cal microscope (Zeiss LSM 410; Axiovert 100; Zeiss 20
Plan-Neofluor; WD 2.0 mm; excitation lines 488 nm for
green and 568 nm for red).
Embryos were also stained in whole mount with MF20 or
QH1. For MF20 or QH1 staining, embryos were fixed in
formalin for 1–2 h, and for MF20 the embryos were
pretreated in a solution of DMSO and methanol (1:4) at
4jC overnight. Embryos were then blocked in 10% normal
goat serum/HBSS for 1 h at RT (MF20), or in 1% BSA
(Sigma-Aldrich, St. Louis, MO) and 0.5% Triton-X-100
(Fisher Scientific, Pittsburgh, PA) in PBS for 30 min (QH1).
Embryos were then incubated in 1:200 dilution of MF20 or
1:2000 dilution of QH1 overnight at 4jC followed by 1:200
dilution of goat antimouse IgG secondary antibody conju-
gated with Alexa Fluor 488 (Molecular Probes) for 3 h at
RT (for MF20) or overnight at 4jC (for QH1). These
embryos were examined by fluorescence stereomicroscopy
(Leica MZ FLIII, Leica Microsystems) and images captured
as described above.
EF5 as an indicator of tissue hypoxia
Twenty microliters of EF5 solution (10 mM) was injected
via the vitelline vein of staged embryos in ovo. This is
approximately 2% of the body weight of the stage 30
embryo. Embryos were incubated for an additional 3 h be-
fore harvesting to distribute the EF5 throughout the embryo,
based on its estimated serum half-life of 1–2 h in young
chicks and rodents (Shapiro et al., 1997). EF5 binding was
detected by immunohistochemistry as described above.
Selected sections were costained with Sr-1 to define the
myocardium. For embryos incubated in hyperoxia, embryos
in the egg were preincubated in 95% O2/5% CO2 for 3
h before EF5 injection and dissected after overnight incu-
bation. For hypoxia, embryos in the egg were injected with
EF5 and after 1 h incubated in 5% O2 for 2 h and
individually harvested from the hypoxia chamber.
LysoTracker Red (LTR) staining for the detection of
apoptotic cells
LysoTracker Red (LTR) (Molecular Probes) is a fluores-
cent acidotropic probe that accumulates in acidic organelles
such as lysosomes with high selectivity (Anderson and Orci,
1988). It is a sensitive method for detecting apoptosis in
mouse (Zucker et al., 1998) and chick (data not shown)
embryos. Embryos were dissected and incubated in 2.5 AM
LysoTracker Red at RT for 15 min with shaking. The
embryos were washed three times in PBS for 10 min with
shaking. The stained embryos were fixed in formaldehyde
for 1–2 h, embedded in paraffin and sectioned by standard
methods. Selected sections were costained for MF20 or Sr-1
to define the myocardium.Analysis of the expression of vascular endothelial growth
factor (VEGF)
Total RNA was collected from dissected atrial, ventric-
ular, and OFT tissues from stage 16–32 chick embryos
using the Absolutely RNAk RT-PCR Miniprep Kit (Stra-
tagene, La Jolla, CA) according to the manufacturer’s
instructions. Tissues from 10–20 embryos depending on
the stage and sample were pooled to obtain sufficient
quantities of RNA. RT-PCR was performed to detect the
expression of VEGF-A mRNA and to determine the ratios
of splice variant isoforms of VEGF-A with standard meth-
ods as previously described. In brief, 1 Ag of RNA was
reverse transcribed with SuperScriptk II reverse transcrip-
tase (Invitrogen, Carlsbad, CA) and oligo-dT. The PCR
reaction consisted of 30 cycles of 30 s at 95jC, 30 s at
55jC, and 1 min at 72jC, with chick VEGF-specific sense
(5V-CAACCATGAACTTTCTGCTCACTTGG-3V) and anti-
sense (5V-AGAAATCAGGCTCCAGAAACAGG-3V) pri-
mers. These primers correspond to nucleotides 1–26 and
704–682 of chick VEGF-A cDNA, respectively. The PCR
products were electrophoresed in 2% agarose gel, stained
with ethidium bromide and band intensities directly quan-
tified with GelDoc camera and Multi-Analyst software
(BioRad, Hercules, CA). RT-PCR of glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) was also performed
as an internal control with chick GAPDH-specific sense (5V-
ACCACTGTCCATGCCATCAC-3V) and antisense (5V-TC-
CACAACACGGTTGCTGTA-3V) primers, corresponding to
nucleotides 576–595 and 1027–1008 of chick GAPDH
cDNA, respectively.
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EF5 binding in the OFT myocardium
We first examined EF5 binding in the stage 30 (ED 7)
chick embryo, a stage at which apoptosis in the OFT
myocardium peaks in prevalence (Watanabe et al., 1998).
Intense EF5 immunoreactivity was detected in the OFT
myocardium of the stage 30 chick embryo relative to the
ventricles, atrium, epicardium, and cardiac cushions (n = 5)
(Figs. 1A,C). No signal was detected when the anti-EF5
antibody was preincubated with EF5 (Figs. 1B,D), or in
embryos infused with vehicle (physiological saline) alone
(n = 2) (data not shown). To estimate the degree of tissue
hypoxia, EF5 immunoreactivity was compared between stage
30 OFT myocardium and embryonic chick ventricles gassed
with nitrogen for 45 min in vitro in the presence of EF5.
Tissues were then processed in parallel. The intensity of EF5
immunoreactivity in the OFT myocardium of the stage 30
chick embryo was similar to that of hearts incubated in close
to anoxic conditions (Figs. 1E,F). These results suggest that
OFT myocardium at stage 30 is significantly hypoxic relative
to the remainder of the heart and embryo.
Fig. 1. Immunohistochemical detection of EF5 binding in the stage 30 chick embryo. Chick embryos were injected with a chemical indicator of hypoxia, EF5,
and processed for immunohistochemical detection of EF5 binding as described in Materials and methods. Immunoreactivity for EF5 was detected in the OFT
(A, arrowheads). Preincubation of anti-EF5 antibody with EF5 abolished the immunoreactivity, showing that the binding of antibody was specific (B). (C,D)
Costaining of the section shown in A and B with Sr-1, an antibody against sarcomeric a-actin, delineates the myocardium. EF5 reactivity was restricted in the
heart to the OFT myocardium (C). (E,F) As a positive control, the intensities of EF5 immunoreactivity were compared between hearts in ovo and ventricles
incubated in EF5 and 0.1% oxygen in vitro. The pictures of EF5 staining were taken at identical exposures using Spot RT digital camera software. Scale bars,
500 Am in A–D; 100 Am in E,F.
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To analyze the time course of the relative tissue hypoxia
in the myocardium of the OFT, we examined EF5 binding
for stages 25 (ED 5), 27 (ED 6), 30 (ED 7), and 32 (ED 8) of
chicken development. These stages represent the period of
cardiomyocyte-apoptosis-dependent OFT remodeling
(Watanabe et al., 1998). Sections were costained with Sr-
1, an antibody to sarcomeric actin that specifically labels
myocardium (Figs. 2E–H). The OFT myocardium is iden-
tified by arrowheads in Figs. 2E–H. The OFT myocardium
staining for EF5 was faintly detected at stage 25. The
staining was increased in intensity at stage 27, maximum
at stage 30, and diminished by stage 32 (Fig. 2, n = 2 for
each stage). The shortening of the OFT myocardium fromstages 25–32 is also evident. The prong of myocardium
extending into the OFT that is EF5 positive is also evident
in Fig. 3B (compare with Fig. 2C), in which the myocardi-
um is defined by the MF-20 (antimyosin) antibody. The
developing liver was also strongly positive as early as stage
25 and throughout these stages relative to the remainder of
the embryo (Figs. 2A,E, arrows). We also compared the
localization of EF5 binding with cardiomyocyte apoptosis
with the use of LysoTracker Red (LTR), which is concen-
trated in acidic lysosomes that accumulate during apoptosis
(Zucker et al., 1998). EF5 immunoreactivity and LTR signal
colocalized in the myocardium of the cardiac OFT of the
stage 30 embryo (Fig. 3). In previous studies, we have
shown cardiomyocyte apoptosis in the proximal and distal
OFT myocardium between stages 25–32, with a peak
Fig. 2. Stage dependence of EF5 binding in the OFT. EF5 binding was examined in stage 25 (ED 5) to 32 (ED 8) chick embryos, the period of OFT
cardiomyocyte apoptosis and remodeling (A–D). The specimens were also costained with Sr-1 (E–H). The immunoreactivity for EF5 was barely detected in
myocardium of cardiac OFT at stage 25 (ED 5) (A,E, arrowheads), and increased in intensity at stage 27 (ED 6) (B,F, arrowheads). The intensity of the signal
was maximal at stage 30 (ED 7) (C,G, arrowheads), then diminished at stage 32 (ED 8) (D,H, arrowheads). This time course paralleled with that of
cardiomyocyte apoptosis of chick OFT (Watanabe et al., 1998). The liver was also strongly positive (A,E arrows). The pictures of EF5 staining were taken at
identical exposures using Spot RT digital camera software. Scale bars, 500 Am.
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fer et al., in press; Watanabe et al., 1998). Thus there is a
temporal and spatial association between relative myocar-
dial hypoxia in the OFT as measured by EF5 binding, and
cardiomyocyte apoptosis as measured by LTR in this study
and several other assays in previous studies.
Effects of modulation of oxygen concentrations
Stage 26 chick embryos were incubated in the egg in 95/
5% O2/CO2 for 4 h, injected with EF5, and harvested for
analysis 1 day later (stage 30) as described in Materials and
methods. Control embryos were subject to the same protocol
except that they were incubated in normoxia (21% O2).
Control and experimental embryos were then processed for
EF5 staining in parallel (n = 3 each). EF5 immunoreactivity inFig. 3. EF5 binding in the OFT myocardium colocalized with LTR staining, an ind
Sr-1 (green) or (B) LTR (red) and MF20, an antibody against myosin, (green). The
Scale bars, 500 Am.the OFT myocardium was markedly diminished in embryos
incubated in hyperoxia (Figs. 4B,D) compared with that in
normoxia (Figs. 4A,C). The signal was, however, still above
background. We next examined the effect of hypoxia by
injecting EF5 to stage 24–25 embryos in the egg and
incubating them in 5% oxygen for 2 h as described in
Materials and methods. Control embryos were subject to
the same protocol except that they were incubated in nor-
moxia (21% O2). Control and experimental embryos were
then processed for EF5 staining in parallel (n = 2 each). The
signal for EF5 was significantly increased in the embryos
exposed to hypoxia as compared to control embryos in all
myocardial compartments, as well as the liver (Figs. 4E,F).
These results indicate that the EF5 binding in the OFT
myocardium is dependent on oxygen concentrations, and
that the tissue hypoxia can be reduced by hyperoxic exposure.icator of apoptosis. Stage 30 embryos were costained for (A) EF5 (red) and
staining of EF5 and LTR colocalized in the OFT myocardium (arrowheads).
Fig. 4. Response of EF5 binding to changes in ambient oxygen concentrations. EF5 binding in stage 30 chick embryo incubated in (A) normoxia and (B)
hyperoxia (95% O2/5% CO2). Intensity of EF5 immunoreactivity in OFT myocardium was diminished (B, arrowheads) compared with control (A, arrowheads).
The sections were costained with Sr-1 to delineate the myocardium (C,D). In stage 25 embryo incubated in 5% oxygen, the intensity of EF5 immunoreactivity
throughout the myocardium (arrowheads) and liver (arrows) was augmented as compared to embryos incubated under normoxic conditions (E,F). The pictures
of EF5 staining were taken at identical exposures using Spot RT digital camera software. Scale bars, 500 Am.
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One of the most potent responses to tissue hypoxia is the
induction of an angiogenic response in part mediated by
expression of VEGF and their receptors (reviewed in
Carmeliet and Collen, 2000). We therefore examined the
expression of these genes in the developing heart and OFT
during the stages of OFT myocardial hypoxia and apoptotic
remodeling. The chicken VEGF-A gene gives rise to four
isoforms generated by alternative splicing of exons
(VEGF122, VEGF146, VEGF166, and VEGF190, homol-
ogous to human VEGF121, VEGF145, VEGF165, and
VEGF189, respectively) (Sugishita et al., 2000; Tischer et
al., 1991). We examined the expression of the VEGF-A
isoforms by RT-PCR of total RNA isolated from pooled
chick embryo heart OFT, atrial, and ventricular tissues from
various stages. Four bands corresponding to the fourVEGF-A isoforms were detected in OFT, ventricles, and
atrial extracts throughout the period of development exam-
ined (Figs. 5A,B and data not shown). However, the
expression of VEGF-A isoforms differed between the
OFT and the other cardiac chambers in a stage-dependent
fashion. In both the ventricles and atria, the transcript
coding for the VEGF166 (predominantly matrix-bound)
isoform predominated over that of the VEGF122 (diffus-
ible) isoform (Houck et al., 1992) at a ratio of approxi-
mately 2:1 (Fig. 5B). In contrast, in the OFT, the VEGF166
transcript was predominant at stages 21–23, but during the
stages when the OFT myocardium was hypoxic as mea-
sured by EF5 binding (25–32), the expression of VEGF122
transcript was similar to or even slightly higher than that of
the VEGF166, with each transcript accounting for approx-
imately 35–45% of the total VEGF-A transcripts (Fig. 5A).
During these same developmental stages, VEGF122
Fig. 5. Expression of the VEGF isoforms in the OFT. VEGF-A isoforms
were analyzed by RT-PCR of total RNA collected from (A) OFTs and (B)
ventricles of staged and pooled embryo hearts. Products were separated by
2% agarose gel electrophoresis and stained with ethidium bromide. RT-PCR
of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is shown as an
internal control. Signal intensities of bands corresponding to VEGF190,
166, 146, and 122 were directly quantified using a GelDoc 1000 camera
and Multi-Analyst software (BioRad), and expressed as a percentage of
total VEGF-A. All four isoforms of VEGF-A were detected at all stages.
However, there was a shift to predominant expression of the VEGF122
(diffusible) isoform in the OFT at the stages when this tissue was hypoxic
(25–32). n = 2.
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transcripts in the atria or ventricles (Fig. 5B). The total
VEGF-A transcript level varied by less than 20% between
samples, with no difference between OFT and ventricular
samples, when measured alone or when normalized to the
abundance of glyceraldehyde 3-phosphate dehydrogenase
(GAPDH). Thus expression of the transcript that codes for
the diffusible isoform of VEGF-A is enhanced in the OFT
coincident with tissue hypoxia.VEGFR2 expression in the developing OFT
VEGF receptor 2 (VEGFR2), also known as Flk1/KDR
(Matthews et al., 1991; Yamaguchi et al., 1993), is a primary
mediator of angiogenesis (Bernatchez et al., 1999; Walten-
berger et al., 1994), and its expression may be regulated by
hypoxia (Brogi et al., 1996; Elvert et al., 2003; Walten-
berger et al., 1996). We examined expression of VEGFR2
by immunohistochemistry in stage 30 chick embryos, the
stage at which EF5 binding in the OFT myocardium was
maximal. Immunoreactivity for VEGFR2 was detected as
previously described in the endocardium and in the endo-
thelium of the aorta and pulmonary artery (Wilting et al.,
1997; Yamaguchi et al., 1993) (Fig. 6A). Interestingly,
immunoreactivity for VEGFR2 was also detected in a
diffuse pattern in the distal OFT myocardium (Fig. 6A,
arrow). No signal was detected when the anti-VEGFR2
primary antibody was omitted from the staining protocol
(Fig. 6B). To confirm that the VEGFR2 staining was within
the myocardial compartment of the OFT, we show that
VEGFR2 and phalloidin-Alexa Fluor 568, which binds to
filamentous actin and thus identifies myocytes, colocalize in
the distal OFT (Figs. 6C, arrow, and D). VEGFR2 staining
was not observed in the ventricular or atrial myocardium.
The finding of VEGFR2 expression in the stage 30 OFT
myocardium raised the possibility that pro-endothelial cells
expressing VEGFR2 had invaded the tissue at this stage. To
examine the relationship between OFT myocardial hypoxia,
VEGFR2 expression and pro-endothelial cell invasion and
vasculogenesis, we utilized an antibody against the quail
QH1 epitope that specifically recognizes cells in the endo-
thelial lineage (Pardanaud et al., 1987). At first, we per-
formed whole-mount staining with QH1 to analyze the
migration of endothelial cells into the OFT. At stage 25,
QH1-positive cells were detected at the base of the OFT
(Fig. 7A), over the surface of the ventricles and as expected
on the endocardial surface. At stage 28, there were increased
numbers of QH1-positive cells concentrated at the base of
the OFT (Fig. 7B). A second focus of QH1-positive cells
was evident at the distal rim of the receding OFT myocar-
dium, with some evidence of vascular patterning (Fig. 7B).
By stage 30, a well-organized QH1-positive vascular net-
work was evident over the surface of the OFT myocardium
extending into the aortico-pulmonic sulcus (also note the
shortening and rotation of the OFT as compared to stage 25
in Fig. 7A). At this stage, few QH1-positive cells were
evident over the ventricles or atria nor had a vascular
network yet formed in these tissues (Fig. 7C). We next
examined QH1 and VEGFR2 staining in sections to coloc-
alize their expression. In the stage 28 quail embryo, which is
comparable to the stage 30 chick embryo, immunoreactivity
for VEGFR2 was detected in the distal OFT myocardium in
a pattern similar to that of the chicken embryo (Fig. 7D,
arrow). The anti-QH1 antibody labeled many of the cells/
structures that were positive for VEGFR2, including the
endothelium lining the heart and great vessels, and the
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Fig. 6. Expression of the VEGF receptor 2 (VEGFR2) in the myocardium of the stage 30 OFT. VEGFR2 expression was detected with an anti-VEGFR2
antibody, TSA amplification of the fluorescein isothiocyanate (FITC) signal (Perkin Elmer) as described in Materials and methods. Immunoreactivity for
VEGFR2 was detected in the endothelium lining the heart and blood vessels and in the distal portion of the OFT of a stage 30 embryo (A, arrow). (B) Signal is
not detected in the heart when the primary antibody is omitted, but the liver is still strongly positive (arrowheads) due to endogenous peroxidase activity. (C)
Costaining for VEGFR2 (green) and phalloidin-Alexa Fluor 568 (red), which binds to F-actin selectively and delineates the myocardium. The VEGFR2 (green)
expression in the OFT colocalized with the phalloidin staining of the myocardium (red) (bracket). (D) Microphotograph of costaining for VEGFR2 (green) and
phalloidin-Alexa Fluor 568 (red) taken with confocal microscope. Immunoreactivity for VEGFR2 (green) was clearly detected in myocardium (red). Scale bars,
500 Am in A,B; 100 Am in C; 25 Am in D.
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the distal rim of the OFT myocardium also observed in
whole mount (Fig. 7D,E, arrowheads). A subset of QH1-
positive cells in the OFT mesenchyme appeared to be
VEGFR2 negative, suggesting that QH1 may be an earlier
marker of the endothelial cell lineage. The OFT myocardi-
um was VEGFR2 positive but negative for QH1 staining in
the stage 28 quail embryo (Fig. 7E, arrow), indicating that
the VEGFR2 expression in that region of the myocardium is
not due to invading endothelial cells at this stage. At later
stages (30), QH1 staining is clearly visible in the distal OFT
myocardium in discrete cells (Fig. 7F, arrowheads), while
the VEGFR2 expression is diffuse (Fig. 6). These results
indicate that the cardiomyocytes of the distal OFT express
VEGFR2 before the invasion of the OFT myocardium by
QH1-positive pro-endothelial cells, and that organization of
pro-endothelial cells into a vascular network occurs in the
epicardial and mesenchymal components of the OFT coin-
cident with OFT myocardial hypoxia.
The stage-dependent intensity of staining of VEGFR2 in
the OFTmyocardium paralleled that of EF5 (data not shown),
suggesting that OFT myocardial hypoxia may trigger
VEGFR2 expression. To test this, stage 30 embryos were
incubated in hyperoxic air for 48 h from stage 25 to blunt thehypoxic stimulus. These embryos showed markedly reduced
expression of VEGFR2 in the OFTmyocardium as compared
to stage-matched control embryos (Fig. 8, n = 2 each). Thus
VEGFR2 expression in the OFT myocardium is triggered by
tissue hypoxia.
Effect of continuous exposure to hyperoxia on OFT
remodeling
To experimentally test the role of hypoxia in OFT
remodeling, chick embryos in the intact egg were continu-
ously exposed to 95% O2/5% CO2 during this specific
developmental window (stages 25–32). This regimen nearly
completely reversed EF5 binding to the OFT myocardium
(Fig. 4). Morphology was examined at stages 31–32, when
OFT remodeling is largely complete, and beyond which
stage the experimental embryos did not survive. In the
control embryos at stages 31–32, most of the shortening
and rotation of the OFT has occurred (Fig. 9A). The OFT
myocardial remnant, defined in whole mount by staining
against light meromyosin, connects the pulmonary artery to
the right ventricle in an anterior position (Figs. 9C,E). The
aorta is in a posterior position and connects directly to the
left ventricle without any significant intervening myocardi-
Fig. 8. Effect of hyperoxia on VEGFR2 expression in the myocardium of the stage 30 OFT. Control stage 30 chicks (A,C) or after 48 h of incubation in
hyperoxia (B,D) were stained with an anti-VEGFR2 antibody (A,B) and costained with phalloidin-Alexa Fluor 568 (C,D). Tissues were sectioned, stained, and
images were captured in parallel. Immunoreactivity for VEGFR2 was detected in OFT myocardium in normoxic embryos (A,C, arrows). This signal was
markedly diminished in embryos incubated in hyperoxia from stage 25 (B,D, arrows). Scale bars, 200 Am.
Fig. 7. Costaining for VEGFR2 and the pro-endothelial cell marker QH1 in the quail OFT. Endothelial cell migration into OFT was examined in stage (A) 25,
(B) 28, and (C) 30 quail embryos by whole mount-staining with QH1. QH1-positive cells were detected at the base of OFT at stage 25 (A, arrow). (B) At stage
28, the number of QH1-positive cells in OFT was increased (arrows), and tiny vascular patterning was detected at the rim of OFT (arrowhead). (C) The QH1-
positive vascular formation was observed in OFT at stage 30. (D) VEGFR2 expression in the distal OFT myocardium in the analogous stage 28 quail embryo
(arrow). (E) Staining of an adjacent section for QH1 showed that the OFT myocardium was VEGFR2 positive but QH1 negative, indicating that the VEGFR2
expression in this tissue at this stage is not derived from invading pro-endothelial cells. In contrast, VEGFR2 and QH1 were colocalized in the OFT
mesenchyme particularly where vessels appear to be forming (D,E, arrowheads). In later stages of OFT development (stage 30 quail embryo), QH1 (F, green)-
positive cells were observed within the myocardium (Sr-1 staining, F, red), indicating invasion of the OFT myocardium by pro-endothelial cells (arrowheads).
At this stage, QH1-positive vascular formation was evident over the surface of the OFT myocardium (arrows). Scale bars, 500 Am in A–C; 100 Am in D–F.
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Fig. 9. Effect of continuous hyperoxia on the remodeling of the OFT. Hearts from control (A,C,E,G) and hyperoxia (95% O2/5% CO2) groups, exposed to
continuous hyperoxia from stage 25 until harvest at stage 32. Hearts photographed in whole mount (A,B) and after staining with MF-20 (antimyosin antibody,
C,D) to delineate the myocardium. In the experimental embryo, there is abnormal persistence of myocardium beneath the aorta, and failure of rotation of the
aorta to a posterior position, so that the pulmonary artery and aorta are in a parallel side-by-side configuration (B). In H&E-stained sections, both the aorta and
pulmonary artery connect to the right ventricle (double outlet right ventricle; DORV) in embryos exposed to hyperoxia (F). A ventricular septal defect (VSD) is
also present (H). In the normal avian stage 32 embryo, the PA connects to the RV in a position anterior and to the right of the connection of the aorta to the left
ventricle (E,G). Scale bars, 1 mm in A–D; 500 Am in E–H. PA, pulmonary artery; Ao, aorta; RV, right ventricle; LV, left ventricle.
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oxia, the aorta and pulmonary artery were side by side and
each connected to the ventricles through a myocardialinfundibulum (Figs. 9B,D). In section it was evident that
both great vessels connect through the myocardial infun-
dibulum to the right ventricle, i.e. double-outlet right
Table 1
Profile of embryos incubated in 95% O2/5% CO2 condition
Total
embryos
Survived to
stage 31–32
Side-by-side
Ao and PA
Persistent
myocardium
DORV and
VSD
No defect
79 21/79 (27%) 10/14 (71%) 9/14 (64%) 6/6 (100%) 3/14 (21%)
Ao = aorta; PA = pulmonary artery; DORV = double-outlet right ventricle; VSD = ventricular septal defect.
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defect (VSD) was also observed in the hyperoxia-incubated
embryos (Fig. 9H). The general morphology of the atria and
ventricles appeared to be unaffected. The OFT defects
observed in this embryo were typical of the experimental
group with some variability in severity. We summarized the
profile of embryos incubated in hyperoxia in Table 1. These
OFT abnormalities were found in 8 of 14 embryos incubated
in hyperoxia. These results suggest that hyperoxia disturbs
the shortening and rotation of OFT and induces abnormal
OFT remodeling.
To determine if the OFT dysmorphology may be due to an
effect of hyperoxia on OFT cardiomyocyte apoptosis, we
used LTR staining to quantify the prevalence of apoptosis in
control and experimental embryos. The prevalence of LTR
particles in the OFT myocardium was significantly lower in
the OFT myocardium of stage 30 embryos exposed to
continuous hyperoxia as compared to controls. In embryos
incubated in hyperoxia, apoptotic cells were detected mainly
in the epicardium or mesenchyme and few apoptotic cells
were present in the OFT myocardium (Figs. 10B,D). Count-
ing LTR particles in all sections that included the OFTFig. 10. Effect of hyperoxia on cardiomyocyte apoptosis of the OFT. Control stag
LTR (A,B) and costained with Sr-1 (C,D). LTR signal was detected in OFT myocar
markedly diminished in embryos incubated in hyperoxia from stage 25 (B,D). Cost
in the OFT myocardium in the control embryos (C) but in the mesenchyme andmyocardium of control and experimental embryos showed
that the number of LTR particles was significantly reduced in
embryos exposed to hyperoxia (hyperoxia 119 F 111 vs.
control 882 F 51, n = 3 embryos for each condition, P <
0.005). These results suggest that OFT myocardial hypoxia
is necessary for cardiomyocyte apoptosis and the shortening
and rotation of the OFT in the transition to a dual circulation.Discussion
Regional hypoxia in the OFT myocardium
In this study, we tested the hypothesis that relative
hypoxia in the OFT myocardium may trigger the unique
remodeling of the OFT in the transition to a dual circulation.
We used the binding of the chemical EF5 as an indicator of
relative tissue hypoxia given the difficulty of direct meas-
urements of intracellular oxygen tensions in vivo. We
demonstrated EF5 binding in the embryonic heart with the
OFT myocardium positive in relation to the atrial and
ventricular myocardium, the cushions, and other tissues, ate 30 chicks (A,C) or after incubation in hyperoxia (B,D) were stained with
dium in normoxic embryos (A,C, arrows). The number of LTR particles was
aining with Sr-1 showed that LTR-positive cells were predominantly located
epicardium in experimental embryos (D, arrowheads). Scale bars, 200 Am.
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relative hypoxia in the OFT myocardium is supported by the
near abolition of the signal when embryos are incubated in
continuous hyperoxia. Furthermore, calibration of EF5
binding in vitro showed a close relationship with oxygen
concentrations in embryonic chick ventricular myocardium
(data not shown). In addition to cellular oxygen concen-
trations, EF5 binding is a function of its diffusion into cells,
and the activity of nitroreductases that in a reducing envi-
ronment result in the covalent binding of EF5 within the cell
(Evans et al., 1995). The increased binding of EF5 in the
OFT myocardium is unlikely to be due to differences in
diffusion, since based on anatomic considerations the barrier
to diffusion would be greatest in the OFT. The OFT
myocardium develops as a simple myocardial wall adjacent
to thick (approximately 300 Am) endocardial cushions, well
above the limit of oxygen diffusion in many tissues (Chi-
libeck et al., 1997). In contrast, the ventricles and atria have
a trabecular structure and thin walls that facilitates the
diffusion of oxygen and other substances (Ben Shachar et
al., 1985; Sedmera et al., 2000). It is a limitation to diffusion
in the OFT tissue that we propose results in the relative
hypoxia of the OFT myocardium at these stages, before the
formation of a local vascular network.
The EF5 binding in the OFT cardiomyocytes is also
greater than the immediately adjacent mesenchymal cells of
the endocardial cushions. While a trivial explanation for this
could be a difference in the binding capacity of EF5 in the
two cell types, the more likely explanation is a higher
metabolic activity of the actively contracting OFT cardio-
myocytes, though to our knowledge the metabolic activity
of the embryonic OFT myocardium has not been measured.
In this study, we determined tissues that were most intensely
EF5 positive in relation to a specific developmental process,
OFT remodeling. Whether ventricular myocardium may be
hypoxic relative to other tissues at these or other stages of
development was not examined. A study using pimonida-
zole as an oxygen sensor showed that the rodent ventricular
myocardium was weakly positive at E16.5 of rat develop-
ment (Lee et al., 2001), but the OFT was not examined.
Estimating the degree of hypoxia in vivo is problematic
(reviewed in Koch, 2002). In this study, we have used
indicators of a stress response that together with EF5
binding suggest that the OFT myocardium is relatively
hypoxic during OFT remodeling.
Hypoxia-responsive program of gene expression in the OFT
One of the most potent and well-characterized responses
to tissue hypoxia is the HIF and VEGF-dependent angio-
genic response (Semenza, 2001). Previous studies have
shown the selective expression of members of the HIF gene
family, HIF-1h (also termed ARNT) protein and HIF-2a
(also termed ePAS) transcripts, in the stage 25–32 chick
cardiac OFT (Favier et al., 1999; Walker et al., 1997). In the
current study, we show expression of the VEGFR2 in theOFT myocardium, and not in the atrial or ventricular
myocardium, with a time course that paralleled that of
EF5 binding. This, in combination with suppression of its
expression by hyperoxia, suggests that VEGFR2 is
expressed in response to tissue hypoxia, as suggested by
studies of VEGFR2 transcription, which is synergistically
activated by HIF-2a and Ets proteins in vivo (Elvert et al.,
2003; Kappel et al., 1999, 2000). Although VEGFR2 is
highly expressed in endothelial cells, it is also expressed in
other cell types during development (Wilting et al., 1997),
and may be induced in mature terminally differentiated
muscle and neuronal cells by hypoxia or ischemia (Jin et
al., 2000; Rissanen et al., 2002). In the developing chick,
expression of VEGFR2 is detected in the distal OFT
myocardium, the last myocardium to differentiate from the
secondary heart field (Mjaatvedt et al., 2001; Waldo et al.,
2001). Whether these cells experience the most severe
hypoxic stimulus, or have greater phenotypic plasticity than
other cardiomyocytes, requires further study. The expression
of the VEGF-A ligand also was distinctive in the OFT
during the stages of remodeling. While similar amounts of
total VEGF transcripts were detected by RT-PCR in each
compartment, the OFT was unique in its relatively increased
expression of the exon 6 + 7 skipped transcript that codes
for the VEGF122 (diffusible) isoform. Unique profiles of
VEGF-A splice variant expression have also been demon-
strated in developing mouse and frog organs (Cleaver and
Krieg, 1998; Ng et al., 2001). What regulates VEGF
transcript alternative splicing is unknown. Whether the
unique profile of VEGF splice variants observed in the
current study results from an effect of tissue hypoxia on
VEGF RNA processing requires further study. It will also be
of interest to determine if there is a relationship between the
unique profile of VEGF isoforms in the OFT, recruitment of
pro-endothelial cells to the OFT, and vasculogenesis, as
suggested in other models of vasculogenesis (Carmeliet et
al., 1999; Cleaver and Krieg, 1998; Stalmans et al., 2002).
Tissue hypoxia and apoptotic remodeling of the OFT
Remodeling of tissues in response to hypoxia is complex,
and may involve adaptive changes in gene expression, cell
death by necrosis or apoptosis, or angiogenesis and resto-
ration of normoxia (reviewed in Semenza, 2001). In a prior
study, we showed a time course of cardiomyocyte
programmed cell death in the OFT (Watanabe et al.,
1998), which exactly parallels the stage-dependent binding
of EF5 in the OFT myocardium in this study. Also coinci-
dent is the recruitment of QH1-positive endothelial progen-
itor cells to the OFT and the formation of a vascular network
in the subepicardial space and mesenchyme of the OFT
(Rothenberg et al., 2002; Waldo et al., 1990). To directly test
the role of tissue hypoxia in the remodeling process, the
hypoxic stimulus was minimized by continuous exposure to
hyperoxic air during this specific developmental window.
This significantly reduced the prevalence of apoptosis in the
Y. Sugishita et al. / Developmental Biology 267 (2004) 294–308306OFT myocardium and attenuated the shortening and rotation
of the OFT. Previous studies have examined various
responses of the embryonic chick cardiovascular system to
hyperoxia (and hypoxia) (Asson-Batres et al., 1989;
McCutcheon et al., 1982), but none have specifically
targeted this phase of development. Since the entire egg
was exposed to hyperoxia in the current study, interpretation
of the effects on development of the OFT could be con-
founded by effects remote from the OFT. However, the
incidence of apoptosis in the OFT myocardium was mark-
edly diminished in response to hyperoxia, and the resulting
morphologic defects resembled that when apoptosis is
directly inhibited (Watanabe et al., 2001), supporting a
direct role for tissue hypoxia in the apoptotic remodeling
of the OFT. While it is also possible that hyperoxia could
influence development through a nonspecific toxic effect,
this interpretation of the result seems unlikely, since in this
scenario it would be anticipated that the prevalence of cell
death would be increased, rather than the observed decrease.
These observations raise some questions regarding the
molecular mechanisms by which hypoxia, VEGF, and
related signaling pathways (Brown et al., 2001; Feiner et
al., 2001) may remodel the OFT in the transition to the dual
circulation. (1) Does hypoxia directly induce apoptosis of
the cardiomyocytes? In vitro studies have suggested that
hypoxia plus a second stimulus, such as acidosis, is required
to induce cardiomyocyte apoptosis (Kubasiak et al., 2002;
Webster et al., 1999), but the relevance of these results to
working myocardium in vivo are uncertain. Hypoxia may
up-regulate expression of pro-apoptotic Bcl-2 family mem-
bers BNip3 and Nix in cardiomyocytes (Kubasiak et al.,
2002), leading to apoptosis through the mitochondrial
(Caspase-9) pathway. Hypoxia may also induce expression
of death receptors and their ligands leading to apoptosis
through the Caspase-8 pathway (Tanaka et al., 1994; Yaniv
et al., 2002). Which of these pathways are activated in the
apoptotic remodeling of the OFT remains to be determined.
(2) What is the role of VEGF signaling in OFT remodeling?
The expression of VEGFR2 on the OFT myocardium
suggests the hypothesis that this may serve an autocrine
protective role, as has been demonstrated for VEGF-A
signaling through the VEGFR2/phosphatidylinositol 3-ki-
nase (PI3K)/Akt pathway (Wick et al., 2002) in hypoxia/
ischemia-induced cell death of neuronal cells and skeletal
muscle (Jin et al., 2000; Ogunshola et al., 2002; Rissanen et
al., 2002). Our previous cell fate studies using LacZ or GFP
tags showed that during normal avian development many
OFT cardiomyocytes are eliminated by apoptosis but a
proportion of the OFT cardiomyocytes survive to form the
subpulmonic infundibulum (Watanabe et al., 1998, 2001).
Further study is required to determine if distal OFT cardi-
omyocytes that express VEGFR2 have a lower frequency of
apoptosis as compared to OFT cardiomyocytes that do not
express VEGFR2. It will also be of interest to determine if
autocrine signaling through VEGFR2 promotes survival of
OFT cardiomyocytes, and more generally if the balancebetween survival and death in this cell population is
determined by different repertoires of gene expression.
In conclusion, this data supports a model in which the
unique anatomy of the embryonic avian OFT results in
relative and increasing myocardial hypoxia. The hypoxic
response is proposed to include cardiomyocyte apoptosis, a
unique profile of expression of VEGF-A isoforms and
receptors, and recruitment of pro-endothelial cells and
vasculogenesis. Exposure of embryos to continuous hyper-
oxia significantly attenuated the apoptotic remodeling of the
OFT, resulting in the abnormal connections between the
great vessels and the ventricles that model congenital human
conotruncal heart defects. This suggests that myocardial
hypoxia is a key trigger for the remodeling of the embryonic
OFT in the transition to a dual circulation. Independent
manipulation of each component of the complex response to
hypoxia is indicated to further our understanding of the
molecular basis of this aspect of heart development.Acknowledgments
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